Tactile Systems Technology (TCMD) Competitors $16.86 -0.14 (-0.82%) (As of 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TCMD vs. RXST, INMD, MDXG, ESTA, BLFS, PLSE, AORT, EMBC, CBLL, and LQDAShould you be buying Tactile Systems Technology stock or one of its competitors? The main competitors of Tactile Systems Technology include RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. Tactile Systems Technology vs. RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia RxSight (NASDAQ:RXST) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability. Is RXST or TCMD more profitable? Tactile Systems Technology has a net margin of 5.42% compared to RxSight's net margin of -23.92%. Tactile Systems Technology's return on equity of 9.24% beat RxSight's return on equity.Company Net Margins Return on Equity Return on Assets RxSight-23.92% -14.00% -12.51% Tactile Systems Technology 5.42%9.24%6.56% Which has more risk & volatility, RXST or TCMD? RxSight has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Do insiders and institutionals hold more shares of RXST or TCMD? 78.8% of RxSight shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 9.4% of RxSight shares are owned by company insiders. Comparatively, 1.4% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer RXST or TCMD? Tactile Systems Technology received 328 more outperform votes than RxSight when rated by MarketBeat users. Likewise, 70.04% of users gave Tactile Systems Technology an outperform vote while only 69.70% of users gave RxSight an outperform vote. CompanyUnderperformOutperformRxSightOutperform Votes4669.70% Underperform Votes2030.30% Tactile Systems TechnologyOutperform Votes37470.04% Underperform Votes16029.96% Which has preferable earnings and valuation, RXST or TCMD? Tactile Systems Technology has higher revenue and earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$128.29M10.87-$48.61M-$0.83-41.67Tactile Systems Technology$285.05M1.42$28.51M$0.6525.94 Does the media refer more to RXST or TCMD? In the previous week, RxSight had 9 more articles in the media than Tactile Systems Technology. MarketBeat recorded 12 mentions for RxSight and 3 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.40 beat RxSight's score of -0.04 indicating that Tactile Systems Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Tactile Systems Technology 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer RXST or TCMD? RxSight currently has a consensus target price of $59.00, indicating a potential upside of 70.57%. Tactile Systems Technology has a consensus target price of $23.00, indicating a potential upside of 36.42%. Given RxSight's stronger consensus rating and higher probable upside, equities research analysts plainly believe RxSight is more favorable than Tactile Systems Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Tactile Systems Technology 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 SummaryTactile Systems Technology beats RxSight on 13 of the 19 factors compared between the two stocks. Ad DTIForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedMake sure to check out Gamma Pockets HERE while it’s still widely available Get Tactile Systems Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for TCMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCMD vs. The Competition Export to ExcelMetricTactile Systems TechnologySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$407.95M$4.33B$5.20B$9.14BDividend YieldN/A44.59%5.12%4.29%P/E Ratio25.9424.5287.0517.14Price / Sales1.4252.161,138.53122.78Price / Cash11.6843.4043.2337.84Price / Book2.057.074.804.78Net Income$28.51M$13.64M$120.46M$225.43M7 Day Performance-5.76%-1.57%-0.84%-0.68%1 Month Performance-5.55%-1.55%14.79%1.03%1 Year Performance17.49%38.74%29.53%15.71% Tactile Systems Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCMDTactile Systems Technology3.6748 of 5 stars$16.86-0.8%$23.00+36.4%+18.5%$407.95M$285.05M25.94980Analyst UpgradeRXSTRxSight2.7881 of 5 stars$39.25+5.2%$62.13+58.3%-15.1%$1.58B$89.08M-46.59220Analyst DowngradeINMDInMode3.5257 of 5 stars$18.10-0.9%$22.60+24.9%-24.8%$1.52B$423.75M9.87480Positive NewsMDXGMiMedx Group2.8744 of 5 stars$9.50+3.7%$12.00+26.3%+2.2%$1.40B$342.80M16.65895ESTAEstablishment Labs2.5341 of 5 stars$46.41+0.9%$60.60+30.6%+61.7%$1.30B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2657 of 5 stars$27.19+1.8%$28.29+4.0%+70.9%$1.26B$146.96M-25.19409PLSEPulse Biosciences1.7945 of 5 stars$20.30+15.0%N/A+42.0%$1.25B$700,000.000.00140Insider TradeAORTArtivion2.0656 of 5 stars$29.08+0.5%$31.80+9.4%+58.2%$1.22B$384.90M-1,446.501,500EMBCEmbecta4.0631 of 5 stars$19.86+1.8%$23.00+15.8%+10.1%$1.15B$1.12B14.712,200Positive NewsCBLLCeriBellN/A$29.05-0.6%$32.60+12.2%N/A$1.04B$60.04M0.00N/ANews CoverageLQDALiquidia3.2787 of 5 stars$11.05+1.2%$24.00+117.2%-5.7%$935.24M$15.61M-6.7050Analyst Forecast Related Companies and Tools Related Companies RxSight Alternatives InMode Alternatives MiMedx Group Alternatives Establishment Labs Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives Artivion Alternatives Embecta Alternatives CeriBell Alternatives Liquidia Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCMD) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tactile Systems Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tactile Systems Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
